![]() |
Volumn 17, Issue 2, 2008, Pages 110-114
|
The US drug safety system: Role of the pharmaceutical industry
c
IL
(United States)
|
Author keywords
Biotechnology industry; Drug safety; Institute of medicine; Pharmaceutical industry; Pharmacoepidemiology; Pharmacovigilance
|
Indexed keywords
DRUG;
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
CONSUMER ADVOCACY;
CONSUMER HEALTH INFORMATION;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG QUALITY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
INFORMATION DISSEMINATION;
MEDICAL ETHICS;
MEDICAL EXPERT;
MEDICAL SOCIETY;
MEDICATION ERROR;
PHARMACOEPIDEMIOLOGY;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
PROFIT;
PUBLIC HEALTH SERVICE;
RESPONSIBILITY;
REVIEW;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
COMMUNICATION;
DRUG INDUSTRY;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PRODUCT SURVEILLANCE, POSTMARKETING;
RISK ASSESSMENT;
UNITED STATES;
|
EID: 39749147799
PISSN: 10538569
EISSN: 10991557
Source Type: Journal
DOI: 10.1002/pds.1467 Document Type: Review |
Times cited : (4)
|
References (15)
|